Empower Genomics with Proteomics
"The proteome as a net with which to catch environmental influences on phenotypes"
In this presentation, Dr. Kári Stefánsson, CEO of deCODE genetics, discusses how exploring the proteome and studying proteomics in a hypothesis-independent manner is the next revolution in science.
Dr. Stefánsson presents the results from key studies where proteomics has transformed the insights gained from genomics and shares examples from multiple disease areas, including colorectal cancer, psoriasis, and cardiovascular disease, where protein level associations helped understand the biological effect of the variants.
Watch the presentation now to hear Dr. Stefánsson discuss:
- How exploring the proteome and studying proteomics in a hypothesis-independent manner is the next revolution in science
- That humans are a product of both the genotype and phenotype, and plasma proteomics is the connection between the two
- How proteomics has influenced the insights gained from genetic research into diseases such as colorectal cancer, psoriasis and cardiovascular disease
- The accuracy of a protein-level mortality prediction model and the factors inversely correlating with risk of death
Speaker
Dr. Kári Stefánsson
CEO, deCODE genetics, Iceland